Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 480 participants.

Also called NCT05165251

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 480 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05165251
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05165251. Randomized; no masking; primary purpose treatment. Start 2022-01-04 (actual); primary completion 2024-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension
Condition
Isolated Systolic Hypertension
Intervention (Drug)
Amlodipine/Atorvastatin 5 Mg-10 Mg ORAL TABLET
Intervention (Drug)
Amlodipine 5mg
Intervention (Other)
Lifestyle intervention
Lead sponsor
Shanghai Jiao Tong University School of Medicine (class: other)

Record details

Record id
cardio:ct-nct05165251
Content hash
e8816b4ce5e4659966fd3cc1adea675b22f13105c6a45fb63bc07167508ecd05